Epidemiology of candidemia in Latin America: a laboratory-based survey
dc.contributor.author | Nucci, Marcio | |
dc.contributor.author | Queiroz-Telles, Flavio | |
dc.contributor.author | Alvarado-Matute, Tito | |
dc.contributor.author | Tiraboschi, Iris | |
dc.contributor.author | Cortes, Jorge | |
dc.contributor.author | Zurita, Jeannete | |
dc.contributor.author | Guzman-Blanco, Manuel | |
dc.contributor.author | Santolaya, Maria | |
dc.contributor.author | Thompson, Luis | |
dc.contributor.author | Sifuentes-Osornio, Jose | |
dc.contributor.author | Echevarria, Juan | |
dc.contributor.author | Colombo, Arnaldo | |
dc.date.accessioned | 2017-04-17T14:10:49Z | |
dc.date.available | 2017-04-17T14:10:49Z | |
dc.date.issued | 2013 | |
dc.description.abstract | BACKGROUND: The epidemiology of candidemia varies depending on the geographic region. Little is known about the epidemiology of candidemia in Latin America. METHODS: We conducted a 24-month laboratory-based survey of candidemia in 20 centers of seven Latin American countries. Incidence rates were calculated and the epidemiology of candidemia was characterized. RESULTS: Among 672 episodes of candidemia, 297 (44.2%) occurred in children (23.7% younger than 1 year), 36.2% in adults between 19 and 60 years old and 19.6% in elderly patients. The overall incidence was 1.18 cases per 1,000 admissions, and varied across countries, with the highest incidence in Colombia and the lowest in Chile. Candida albicans (37.6%), C. parapsilosis (26.5%) and C. tropicalis (17.6%) were the leading agents, with great variability in species distribution in the different countries. Most isolates were highly susceptible to fluconazole, voriconazole, amphotericin B and anidulafungin. Fluconazole was the most frequent agent used as primary treatment (65.8%), and the overall 30-day survival was 59.3%. CONCLUSIONS: This first large epidemiologic study of candidemia in Latin America showed a high incidence of candidemia, high percentage of children, typical species distribution, with C. albicans, C. parapsilosis and C. tropicalis accounting for the majority of episodes, and low resistance rates. | |
dc.format.extent | 7 | |
dc.identifier.citation | PLoS One, 2013; 8(3): e59373 | |
dc.identifier.uri | http://hdl.handle.net/11447/1154 | |
dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0059373 | |
dc.language.iso | en_US | |
dc.publisher | PLoS | |
dc.subject | Candida | |
dc.subject | Candidemia/drug therapy | |
dc.subject | Candidemia/epidemiology | |
dc.subject | Fluconazole/therapeutic use | |
dc.title | Epidemiology of candidemia in Latin America: a laboratory-based survey | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Epidemiology of Candidemia in Latin America A Laboratory-Based Survey.PDF
- Size:
- 191.77 KB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo